Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.
作者信息
Tian Wen-Ning, Huang Yu-Hong, Dai Cong
机构信息
Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, China.
出版信息
Inflamm Bowel Dis. 2022 Oct 3;28(10):e134-e136. doi: 10.1093/ibd/izac118.
Abstract
摘要
相似文献
1
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种对炎症性肠病活动及疫苗相关不良事件发生的影响：一项来自中国的调查
Inflamm Bowel Dis. 2022 Oct 3;28(10):e134-e136. doi: 10.1093/ibd/izac118.
2
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.抗 SARS-CoV-2 疫苗在炎症性肠病患者中的实施情况和短期不良事件：一项国际网络调查。
J Crohns Colitis. 2022 Aug 4;16(7):1070-1078. doi: 10.1093/ecco-jcc/jjac010.
3
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.SARS-CoV-2 疫苗接种对炎症性肠病活动和疫苗相关不良事件发展的影响：来自 PREVENT-COVID 的结果。
Inflamm Bowel Dis. 2022 Oct 3;28(10):1497-1505. doi: 10.1093/ibd/izab302.
4
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.新型冠状病毒疫苗在炎症性肠病患者中的安全性：系统评价和荟萃分析。
Dig Liver Dis. 2022 Jun;54(6):713-721. doi: 10.1016/j.dld.2022.03.005. Epub 2022 Mar 22.
5
Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease.炎症性肠病患者接种 SARS-CoV-2 疫苗后的不良事件和血清学反应。
Am J Gastroenterol. 2023 Sep 1;118(9):1693-1697. doi: 10.14309/ajg.0000000000002337. Epub 2023 Jun 22.
6
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.免疫抑制和生物治疗的炎症性肠病患者的 SARS-CoV-2 疫苗接种的疗效和安全性：前瞻性观察研究。
PLoS One. 2022 Sep 2;17(9):e0273612. doi: 10.1371/journal.pone.0273612. eCollection 2022.
7
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.炎症性肠病患者及有注射疗法反应史患者的新冠病毒疫苗接种情况
Inflamm Bowel Dis. 2021 Jul 27;27(8):1358-1360. doi: 10.1093/ibd/izab094.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.炎症性肠病患者接种新冠疫苗后血清转化缺失是感染新冠病毒的独立危险因素：来自IG-IBD研究ESCAPE-IBD的数据
Inflamm Bowel Dis. 2024 May 2;30(5):854-858. doi: 10.1093/ibd/izad118.
10
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
Zotero 插件